Solid Phase Oligonucleotide Synthesis Is Not Obsolete - It Is Ascending
Solid-phase oligonucleotide synthesis remains the backbone of therapeutics, with flow-enabled SPOS delivering unmatched control, scalability, and regulatory reliability.
Publications & guides
Scientific explanations, protocols, references, industry perspectives and company news.
9 of 68 resources
Solid-phase oligonucleotide synthesis remains the backbone of therapeutics, with flow-enabled SPOS delivering unmatched control, scalability, and regulatory reliability.
AI promises to transform biotech, but real-world results are more incremental. A practical perspective on AI in drug discovery, genomics, diagnostics, and lab automation.
Discover kbDNA’s rapid workflow for repurifying rituximab biosimilars to high-purity standards—featuring SEC overlays, gel schematics, and SOPs.
Unfiltered truths, hidden risks, and real data behind life sciences R&D in North America. Discover the facts nobody else is sharing—read the full report now
This article explores the complexities of biosimilars, including their development process, regulatory challenges, economic impact, and future prospects. It highlights the potential of biosimilars to reduce healthcare costs and increase patient access to biologic therapies, providing valuable insights for biopharmaceutical and academic researchers.
A look back at major biotechnology deals and trends from the decade leading up to the 2025 J.P. Morgan Healthcare Conference.
The FLAG tag (DYKDDDDK) is an epitope tag widely utilized in biopharmaceutical research for protein purification, detection, and functional analysis. This article provides an in-depth examination of FLAG tag technology, its advantages, limitations, and diverse applications. Additionally, it explores current research trends and future directions in FLAG tag technology, making it a pivotal tool in advancing drug discovery and development.
Discover the latest advancements in peptide synthesis at kbDNA. Learn about innovative techniques, optimized reagents, and cutting-edge technologies that enhance research efficiency and outcomes.
Discover essential tips and protocols for handling and preparing synthesized peptide sequences. Learn how to tailor your approach to the unique characteristics of your peptides to ensure successful outcomes in your research
What are Polyclonal Antibodies? pAbs are diverse antibodies from various B-cell clones, binding multiple epitopes & enabling vast interaction with targets.
Discover the transformative impact of CRISPR-Cas9 in biomedical research and genetic engineering, covering its mechanism, applications, challenges, and ethical considerations. The article also highlights alternative CRISPR systems like Cas12 and Cas13.
"Explore the critical role of membrane proteins in medicine. Learn how understanding their structure informs drug development, shaping the future of healthcare."
Unlock the complexities of protein characterization in bio-pharmaceutical research. Explore methods, applications, and emerging trends.
Discover protein linkers' diverse roles: from structural stability to cell signaling in molecular engineering.
Discover how Fusion Proteins revolutionize gene editing, nanotechnology, and synthetic biology, driving breakthroughs in science and medicine.
A February 2024 announcement describing kbDNA’s former recombinant protein production, purification, and related services.
Learn about monoclonal antibodies: their history, production, types, and applications in medicine. Dive into challenges, future prospects & more.
Explore the advantages of recombinant antibodies. Discover their applications in research, diagnostics & therapeutics. Transform your R&D with precision.
An October 2023 overview of research-grade reagents and factors that affect their suitability for discovery-stage research.
It is clear that the failure of Silicon Valley Bank (SVB) has had a significant impact on the biotech industry, especially in the greater Boston area where many startups rely on the bank's lending services. The sudden closure of the bank and the risk of severe losses for large depositors had caused panic among clients, leading to a bank run and further financial losses for the bank.The impact of SVB's failure on biotech companies goes beyond just the financial losses. The biotech industry has already been going through a challenging period of layoffs and budget cuts, and the loss of a major lending institution like SVB could exacerbate these challenges. However, the quick response from federal regulators and regional agencies in fully protecting deposits and providing relief measures is a positive development.
Microarray is a versatile and high-throughput method to explore genome and parallel genes data sets with unpredictable functions & variety of samples. After kb original protocol, this version dives deeper into the newer experiment challenges and provides an updated copy to help your experiments
Examples of bioconjugation based hybrid molecules include protein structure elucidation using tags, enzyme immobilization, antibodies binding to fluorophores, cellular imaging, microarrays, etc.
Gain insight on handling the small units of functional antibodies and their antigen-binding activities. In various expression models, kbDNA's protocol provides a quick guide related to the main aspects of scFv cloning methodology
In order to utilize protein reagents for desired applications, there is urgent requirement of improved quality control (QC) in terms of purity, production and reproducibility. Quality control of protein reagents deemed essential for precise measurement system and ensures reproducibility over time under different operating conditions. Our latest article outlines key aspects of minimal criteria and makes a case for optimizing standard RUO testing.
A May 2022 announcement describing kbDNA’s response to laboratory supply disruptions at the time.
Laboratories depend on research reagents. Time and resources are wasted sourcing commercial DNA, RNA and recombinant proteins and antibodies. Gain a better understanding about reagents for cellular and molecular biological experiments that advance drug discovery
Along with an extensive selection of base-carrying phosphoramidites, our DNA synthesis toolbox includes; standard and mild 3’ base protection options with a variety of CPG supports, functional backbone modifications, duplex stabilizers and more. These compounds allow our synthesis to pursue challenging techniques such as 5’->3’ synthesis and heavy reinforcements to the nucleotides. Additional in-house compounds are categorized into their respective applications. Most notably chain termination for PCR/Sequence Utility, structural studies, DNA mutagenesis/repair, diagnostics, and therapeutics.
Modifying DNA during synthesis involves a bit of creativity along with untraditional chemistry throughout the synthesis workflow. Different classes of modifiers have grown over time, but the most tried and true begins with 3’ or 5’ amino modifiers and the use of spacers and “branching” modifications. This paved the way for introducing more elaborate modifiers into sequences, such as compounded functional groups and a wide array of labels.
Post-translational modifications are extensive and challenging to study. We focus on 10 key chemistries
A 2021 preview of kbDNA's former in-vivo recombinant protein catalog.
As a headline, it is tough to compete with the appeal of the COVID controversy. This can be especially challenging for biotechnology and life science organizations, considering the industry’s role in the pandemic response. In fact, a significant number of those organizations continued their non-COVID research. We were fortunate to work with various laboratory groups and their fascinating research. Many of which achieved significant progress during the pandemic. Read about their compelling research, unrelated to COVID and more in our article
Excerpts from a reference chart for oligo building blocks, organized by nucleotide function and structure class.
Bioseparation studies helped lay the groundwork for innovations in purification techniques. Particularly with the various chromatography methods, its a challenge to analyze principles with parameters to match your experiment criteria. In our new article, we investigate this by focusing on the distinct chemistry of each method; size-exclusion, ion-exchange and affinity chromatography.
A reference guide to multi-protein complex characterization by BN-PAGE. Reagent mix formulations are not included; contact kbDNA for supporting details.
Characterization plays a comprehensive role throughout discovery. For structural biologists, this entails gaining a better understanding of biophysical and dynamic properties relative to their research molecules. While various disciplines continue to help innovate methods used for structural studies-the recent introduction of cryo-electron microscopy (cryo-EM) has been a significant addition to the experimental workflow. In this note, we review and compare primary methods for structural characterization, while exploring the true application potential for Cryo-EM.
Preview of a 2020 white paper on discovery-research CRO management, covering qualification, data analysis and reagent planning.
Post Translational Modifications (PTMs) are a growing focus in protein and bioreagent production. We review the top key understandings and mechanics of PTMs with up-to-date biochemistry.
As the application of oligonucleotides continues to grow in research, advancements in nucleic acid chemistry are expanding manufacturing capabilities-particularly with RNA. Key innovations have optimized traditional synthesis with automation and specialty compounds to help deliver versatile-stable and pure RNA tools to support discovery analysis and solutions for therapeutic designs. In this eBook, we delve deeper into the building block reagents, modifications and technologies guiding the way for versatile synthesis of RNA.
Reviewing the conventional aptamer : antibody side by side comparison. By utilizing our professional experiences with both reagents to highlight some essential oversights between the two, we make a case for implementing both reagents in your experimental workflow to reinforce your discovery platform. Read more about it in this op-ed article!
To further bridge the gap between designing a DNA or RNA sequence and the process of synthesizing it - this review offers a fundamental break-down of the core modifications that help support novel synthesis.
A 2020 preview of kbDNA's third-edition reagent booklet, covering biomarker analysis, characterization, assay development and compound synthesis.
Oligonucleotide aptamer assays have been proven tactical in accelerating drug discovery platforms. Single-site or dual-site binding, the utility of aptamer science offers significant advantages in detecting your target molecules. Learn about oligo-aptamer assays & consider their application in your experiment workflow.
Protein instability analysis screening enzymatic stability activity, efficiency removing GST fusion partner and proteolytic specificity cleaving a diverse range of fusion protein tags using PreScission, factor Xa, and thrombin protease.
The following protocol describes the steps for cleavage of GST-fusion proteins with PreScission Protease.
A 2020 article on quality testing for research-use oligonucleotides, including the checks kbDNA reported at the time.
This latest white paper guides the scientific reader through the in's and out's of biomarker analysis from the bench top perspective. As we make our way through the principle science, this piece hits on essential components of biomarker analysis applications and suggests rational effective solutions for optimizing the process.
The upsurge in infectious disease research prompts immense RNA isolation techniques for sample preparation. High purity extraction of the viral RNA is critical for characterization analysis and drug discovery. Learn how spin-column and magnetic bead-based method compare when it comes to your viral RNA extraction.
In our publication, we provide the current knowledge of linker properties, design and functionality in recombinant fusion protein technology
Explore the topic of drug targeting selectivity in coronaviruses. Analysis of key genomic & structural elements of the virus provides an understanding of the research challenges while making a case for siRNA synthetic reagents for antisense target optimization.
Recent success in targeting covalent inhibitors has increased consideration of covalent molecules in target discovery. Gain insight on the current nucleophile modalities, electrophile warheads & innovative methods helping drug hunters advance small-molecule research.
Whether your lab already has an SOP in place for new protein analysis or would benefit from a revised procedure, we provide a simplified version of kbDNAs in-house Bradford Assay protocol for concentration testing commercial protein reagents.
Relative to the central dogma of molecular biology, our synthetic dogma explains the profiles of DNA, RNA & Protein as analyte-specific research reagents and their applications throughout the workflow of experiments for drug discovery; ssDNA, dsRNA, recombinants
Microarray Spotting techniques can strongly impact the quality of hybridization along with the array analysis. The following series of protocols demonstrate the proper handling of the three most common coated-slides; Epoxy, Aldehyde, & Amine-based. Get more information by visiting our website.
Reference Proteins as Molecular Weight Standards
A 2019 opinion article on the limits of reagent search tools and the information researchers need when sourcing recombinant proteins.
CRISPR/CAS9 is innovating drug discovery & laboratory research methods, but off-targeting remains an issue. Modifying the single guide RNA emerges as an effective solution. Rational design & engineering secondary structure offer capabilities to apply diverse gRNA types as hairpins to optimize specificity.
A helpful guide for the variety of different protein tags - trending in recent growth
Commercializing synthetic research reagents is very complex in the life science industry. Companies are attempting to address the challenges of sourcing proper reagents by way of ecommerce innovation and are faced with the same bottleneck. Discover what factors are limiting product diversity in research.
A 2019 perspective on the challenges of sourcing difficult-to-express recombinant proteins, including kbDNA’s protein work at the time.
Finding the right modifications to build a DNA or RNA sequence can be overwhelming, a problem that has resulted in a growing trend of laboratories dedicating valuable time and money to unnecessary and expensive modifications, sequence designs that overlook biochemistry fundamentals, and widespread misinformation. With a growing need for biochemists in nucleotide synthesis labs, there is an equal need to re-establish an understanding of the different types of modifications and the roles they play in synthesis.
ssDNA, siRNA, gRNA, LNA, BNA & more novel breakthroughs in oligonucleotides for life science research and drug discovery. Discover how versatile synthesis is innovating automated synthesis and shaping the future of biotechnology.
Review of the technical components that drive attachment chemistry in nucleotide synthesis. Building blocks; amidites/phospho-amidites, supports including a wide range of modifications in oligonucleotides for DNA or RNA drug discovery experiments
Reference guide to RNA synthesis building blocks, including phosphoramidites, solid supports, protecting groups and reverse-synthesis options.
kbDNA offers RNA modifications for better maintenance and protection against degradation. We use advanced RNA modifiers equipped with affinity and fluorescent labels.
Our nucleotide synthesis is modeled to introduce technical & chemical optimization from start to finish. We achieve that by utilizing our precision arsenal of formulations to aid & improve very specific moments throughout our solid-phase production. Activation, sulfurizing, phosphorylating and capping reagents help add an extra layer of customization to every project we synthesize. NHS Esters enhance affinity and fluorescence and our mono-,di-, triphosphates offer more control to certain chemical reactions.
Nucleosides & Amidites: The Building Blocks of DNA & RNA
Life Sciences Review included kbDNA in its 2022 list of top synthetic biology companies.